IP Verse

Immunogenic Compositions Comprising Lawsonia Intercellularis

Patent No. EP2992897 (titled "Immunogenic Compositions Comprising Lawsonia Intercellularis") was filed by Boehringer Ingelheim on Mar 14, 2006. The application was issued on Jul 4, 2018.

Patent Summary

Combination vaccines for swine that protect against multiple pathogens, including Lawsonia intracellularis, Bordetella bronchiseptica, Brachyspira pilosicoli, Brachyspira hyodysenteriae, Brucella suis, Porcine Epidemic Diarrhea virus, Clostridium perfringens, Clostridium novyi, Clostridium septicum, Clostridium tetani, Escherichia coli, Encephalomyocarditis virus, Eperythrozoon suis, Erysipelothrix rhusiopathiae, Leptospira interrogans, and Parvovirus. The vaccines induce an immune response against infection by these pathogens, providing protection against diseases such as porcine proliferative enteropathy, swine dysentery, brucellosis, porcine epidemic diarrhea, and others.

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
CEVA SANTE ANIMALEApr 3, 2019CABINET BECKER ET ASSOCIES
INTERVETApr 2, 2019INTERVET

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2992897

BOEHRINGER INGELHEIM
Application Number
EP15162413A
Filing Date
Mar 14, 2006
Status
Revoked
Oct 27, 2023
Publication Date
Jul 4, 2018
External Links
Slate, Register , Google Patents